|  | | | | |
| Company | Gattefossé | Gattefossé | Gattefossé | Gattefossé | Gattefossé |
| Item | LauroglycolTM 90 | Geleol™ Mono and Diglycerides NF | Gelucire® 50/13 | Labrasol® ALF | Suppocire® Series |
| Price | | | | | |
| Vendor Product Page | Company Product Page | Company Product Page | Company Product Page | Company Product Page | Company Product Page |
| Description | Propylene glycol monolaurate (Type II) NF/EP | Mono and diglycerides NF / Glycerol monostearate 40-55 Type I EP / Glyceryl Mono- and Distearate ChP | Stearoyl polyoxyl-32 glycerides NF / Stearoyl macrogol-32 glycerides EP | A nonionic water-dispersible liquid surfactant for lipid-based formulations, Labrasol® ALF is used to solubilize and increase oral bioavailability of poorly water-soluble APIs. Its ability to self-emulsify in aqueous media enables it to form | Hard fat NF/EP/JPE (and) Additive |
| Final Dosage Form | Capsules, emulsions, suspensions, creams, lotions, ointments | Capsules, creams, lotions, ointments | Capsules, emulsions, suspensions | Capsules, emulsions, suspensions, gels, foams, creams, lotions, ointments | Suppositories |
| Functionality | Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions | Modified release matrix former for capsules, coating agent for taste masking, consistency agent | Solubilizer, bioavailability enhancer, and surfactant for poorly-soluble APIs in solid dispersions and SMEDDS, lipid binder in melt processes | Water disperible surfactant, solubilizer and bioavailability enhancer in SMEDDS, topical penetration/permeation enhancer, able to form light foams with pump device (no gas required), low impurities guaranteed for stability and capsule compatibility | Range of bases for rectal/ vaginal suppositories with varying melting points and additives to vary consistency and wetting properties |
| Pharmacopeial Compliance | Yes | Yes | Yes | Inquire | Yes |
| Type | Liquid | Pellets | Pellets | Liquid | Pellets |
| Application | Oral, Topical, Transdermal | Oral, Topical, Rectal/Vaginal | Oral | Oral, Topical, Transdermal | Rectal/Vaginal |
| Get quote | | | | | |